Michael Brownlee
- Clinical Biochemistry top 0.01%
- Advanced Glycation End Products research 37
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes Management and Research 13
- Natural Antidiabetic Agents Studies 9
- Nephrology top 0.1%
- Chronic Kidney Disease and Diabetes 8
- Physiology top 0.05%
- Adipose Tissue and Metabolism 13
- Ophthalmology top 0.2%
-
- Glycosylation and Glycoproteins Research 11
-
- Virus-based gene therapy research 8
- Diabetes and associated disorders 8
Michael Brownlee
105 papers receiving 34.0k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Clinical Biochemistry 10.6k
- Endocrinology, Diabetes and Metabolism 10.5k
- Nephrology 2.4k
- Physiology 8.5k
- Ophthalmology 2.3k
Countries citing papers authored by Michael Brownlee
This map shows the geographic impact of Michael Brownlee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Brownlee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Brownlee more than expected).
Fields of papers citing papers by Michael Brownlee
This network shows the impact of papers produced by Michael Brownlee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Brownlee. The network helps show where Michael Brownlee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Brownlee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 14 | |
| 3 | 2022 | 7 | |
| 4 | 2018 | 31 | |
| 5 | 2014 | 3 | |
| 6 | 2013 | 136 | |
| 7 | 2011 | 156 | |
| 8 | 2009 | 361 | |
| 9 | 2008 | 194 | |
| 10 | 2008 | 36 | |
| 11 | 2006 | 6 | |
| 12 | 2005 | 283 | |
| 13 | Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cellsbreakdown → | 2003 | 629 |
| 14 | Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectinbreakdown → | 2003 | 900 |
| 15 | 2002 | 304 | |
| 16 | 2000 | 411 | |
| 17 | 1996 | 38 | |
| 18 | 1996 | 231 | |
| 19 | 1993 | 17 | |
| 20 | Handbook of diabetes mellitus | 1981 | 77 |
About Michael Brownlee
Michael Brownlee is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 106 papers that have together received 35.1k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (37 papers), Diabetes Management and Research (13 papers), Adipose Tissue and Metabolism (13 papers), Glycosylation and Glycoproteins Research (11 papers), Natural Antidiabetic Agents Studies (9 papers), Virus-based gene therapy research (8 papers), Chronic Kidney Disease and Diabetes (8 papers) and Diabetes and associated disorders (8 papers). The work is most often cited by research in Clinical Biochemistry (10.6k citations), Endocrinology, Diabetes and Metabolism (10.5k citations) and Nephrology (2.4k citations). Michael Brownlee has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Ferdinando Giacco, Anthony Cerami, Helen Vlassara, Xueliang Du, Diane Edelstein, Terry P. Combs, Anders H. Berg, Philipp E. Scherer, Jeffrey S. Flier and Lisa H. Underhill. Their work appears in journals such as Diabetes, Journal of Biological Chemistry, Circulation Research, Diabetes Care and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.